PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2026BioDrugs2 citationsOpen Access

The Market for Monoclonal Antibodies: Trends, Challenges, and Opportunities

AMAndré Soares Motta-SantosKNKenya Valéria Micaela de Souza NoronhaLRLeonardo Costa Ribeiro

Key Points

  • The central aim is to examine the market dynamics surrounding monoclonal antibodies, focusing on their pricing and market structure.
  • Analyzed trends in monoclonal antibody pricing and market influences
  • Identified factors contributing to market concentration
  • Examined the impact of financial investors on drug prices
  • High prices of monoclonal antibodies persist despite their benefits
  • Market concentration raises equity concerns in healthcare access
  • Financial investor influence worsens pricing issues

Abstract

While monoclonal antibodies have transformed modern medicine and improved safety and effectiveness, their persistently high prices, reinforced by market concentration and financial investor influence, raise serious concerns for equity and social welfare.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Motta-Santos et al. (2026) studied this question.

synapsesocial.com/papers/69ccb71716edfba7beb88f4ehttps://doi.org/10.1007/s40259-026-00774-0
Ask AI
Helpful
Bookmark
Share
View Full Paper